Workflow
医疗健康服务
icon
Search documents
大动作!翌耀科技启动上市辅导,复星系再拓资本版图
Bei Jing Shang Bao· 2026-01-08 14:05
值得一提的是,复星高科也是复星系旗下上市公司豫园股份、万盛股份、海南矿业、复星医药的控股股东。若翌耀科技能成功登陆A股市场,也将进一步完 善复星系在智造板块的资本布局。 作为复星智造板块的重要力量,翌耀科技致力于提供高科技解决方案,服务领域涵盖汽车焊装、总装、新能源、一般工业、食品饮料自动化及数字化等多个 智能制造领域。 在当下暗流涌动的资本热潮中,复星系也在暗自发力,欲拓资本版图。 1月7日,证监会官网显示,复星国际旗下的智能科技集团上海翌耀科技股份有限公司(以下简称"翌耀科技")启动上市辅导,欲冲击IPO,若能顺利上市, 复星系也将在A股再落一子。 在掌门人郭广昌的带领下,经过逾30年发展,复星已成为一家创新驱动的全球家庭消费产业集团,战略聚焦健康、快乐、富足的幸福生态系统。截至目前, 郭广昌旗下A股上市公司已有复星医药、豫园股份、舍得酒业、海南矿业、万盛股份、上海钢联6家,其中百亿市值公司4家;港股上市公司则有复星国际、 复锐医疗科技、复星医药、复宏汉霖4家,其中复星医药系"A+H"两地上市。 资本版图扩张背后,复星系旗下上市平台的业绩表现呈现明显分化态势。从郭广昌实控的上市公司最新财报来看,6家公司净 ...
江河集团12月29日获融资买入178.94万元,融资余额9651.39万元
Xin Lang Cai Jing· 2025-12-30 01:34
Group 1 - Jianghe Group's stock increased by 0.25% on December 29, with a trading volume of 21.08 million yuan. The net financing purchase on that day was 21.82 million yuan, with a total financing and securities balance of 97.07 million yuan [1] - The financing balance of Jianghe Group is 96.51 million yuan, accounting for 1.07% of the circulating market value, which is below the 10th percentile level over the past year, indicating a low position [1] - The short selling data shows that Jianghe Group repaid 900 shares on December 29, with a short selling balance of 55.91 million yuan, which exceeds the 90th percentile level over the past year, indicating a high position [1] Group 2 - As of October 31, Jianghe Group had 17,700 shareholders, a decrease of 1.87% from the previous period, with an average of 63,845 circulating shares per person, an increase of 1.91% [2] - For the period from January to September 2025, Jianghe Group reported a revenue of 14.55 billion yuan, a year-on-year decrease of 5.63%, while the net profit attributable to shareholders increased by 5.67% to 458 million yuan [2] - Jianghe Group has distributed a total of 3.308 billion yuan in dividends since its A-share listing, with 1.042 billion yuan distributed in the last three years [2]
复星医药:公司业务布局主要涵盖制药、医疗器械与医学诊断、医疗健康服务三个板块
Zheng Quan Ri Bao Wang· 2025-12-23 13:47
证券日报网讯12月23日,复星医药(600196)在互动平台回答投资者提问时表示,公司业务布局主要涵 盖制药、医疗器械与医学诊断、医疗健康服务三个板块,其中药品、器械及诊断产品的主要市场包括中 国、美国、欧洲及新兴市场在内的多个国家和地区。由于业务范围广、产品结构多元,难以以单一指标 概括整体市场占有率;但从公司在重点治疗领域的产品渗透度以及持续增长的海外收入占比来看,公司 在国内同行业中保持稳固竞争地位,并在国际市场不断提升影响力、扩宽布局。 ...
思派健康回购15.08万股股票,共耗资约35.95万港元,本年累计回购1471.38万股
Jin Rong Jie· 2025-12-18 15:08
思派健康成立于2014年,是一家专注于医疗健康服务的科技企业,主要业务涵盖肿瘤专科管理、医药供 应链及健康保险服务等领域。公司通过数字化平台整合医疗资源,为患者、医生及医疗机构提供一站式 解决方案。2022年12月,思派健康在港交所主板上市,发行价为18.6港元。近年来,公司积极拓展业务 版图,但受行业竞争加剧及政策环境影响,其盈利能力和增长持续性面临挑战。最新财报显示,思派健 康仍处于战略投入期,亏损虽有所收窄,但市场对其商业化能力保持关注。 12月18日,思派健康回购15.08万股股票,每股回购均价2.38港元,共耗资约35.95万港元,本年累计回 购1471.38万股,占总股本1.95%。 截至当日港股收盘,思派健康下跌0.83%,报2.39港元/股。 思派健康近期回购情况 回购日期回购均价回购股数回购金额本年累计回购股数2025-12-182.38415.08万35.95万1471.38万2025- 11-052.47726.32万65.19万1456.30万2025-06-304.7262.00万9.45万1429.98万2025-06-274.7342.00万9.47万 1427.98万2025- ...
京东健康发起亿元品牌联盟 深耕企业健康消费市场
Bei Jing Shang Bao· 2025-12-18 13:52
京东集团副总裁、政企业务总裁李永明在分享中指出,京东深耕政企采购行业超十年,服务超800万家 政企客户,其中涵盖3万多家大型企业,为品牌商构筑广阔增长空间。今年以来,营养、保健、滋补、 医疗器械等健康品类在政企采购赛道呈爆发式增长,超百个细分品类同比增幅突破100%。 面向2026年,京东健康企业业务提出三大发展方向:"根基行动"聚焦供应链与商品能力建设;"燎原计 划"着力于集中采购模式的规模化复制;"倍增之战"则将重点拓展企业医疗金赛道,提供健康福利与理 赔一站式解决方案。 会上,2026京东健康企业业务亿元品牌联盟成立,旨在聚合领先品牌力量,深化生态合作。海氏海诺、 迈瑞医疗、鱼跃电商、同仁堂健康、翔宇医疗五家企业代表参加了启动仪式。 12月18日,京东健康企业业务商家大会暨2026年亿元品牌联盟成立仪式在北京举行。大会围绕"以力聚 新,同心共健"主题,聚焦企业健康消费市场的数字化升级与生态共建,吸引多家健康领域品牌参与。 (文章来源:北京商报) 京东集团SEC委员、京东健康CEO曹冬在致辞中指出,"员工健康即是企业生产力"已成行业共识,企业 健康管理正从福利选项转变为组织发展关键支撑。现场披露数据显示, ...
复星医药(02196.HK):12月11日南向资金增持49.95万股
Sou Hu Cai Jing· 2025-12-11 19:31
Core Viewpoint - Southbound funds have increased their holdings in Fosun Pharma (02196.HK) by 499,500 shares on December 11, with a total net increase of 1,437,000 shares over the last five trading days and 1,806,000 shares over the last twenty trading days [1] Company Overview - Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is primarily engaged in the research, manufacturing, and sales of pharmaceutical products [1] - The company operates through five segments: - Pharmaceutical segment focuses on innovative drugs, mature pharmaceutical products, and vaccine business - Medical devices and diagnostics segment involves the manufacturing and sales of molecular diagnostics, immunodiagnostics, and microbiological diagnostic medical beauty devices - Healthcare services segment operates an integrated online and offline medical service platform - Pharmaceutical distribution and retail segment is involved in the wholesale and retail of pharmaceutical products - Other segments engage in various pharmaceutical-related businesses [1] Shareholding Structure - As of now, southbound funds hold 316 million shares of Fosun Pharma, accounting for 57.28% of the company's total issued ordinary shares [1]
卓悦控股(00653) - 自愿性公告关於达成战略合作计划之谅解备忘录
2025-12-11 11:02
自願性公告 關於達成戰略合作計劃之 諒解備忘錄 本公告乃由卓悅控股有限公司(「本公司」,連同其附屬公司,統稱「本集團」)自願作 出,以知會本公司股東(「股東」)及有意投資者有關本集團業務發展之最新消息。 可能合作計劃 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責, 對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明,並 明 確 表 示,概 不 對 因 本 公 告 全 部 或 任 何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Bonjour Holdings Limited 卓悦控股有限公司 (於開曼群島註冊成立之有限公司) (股份代號:653) 本 公 司 董 事(「董 事」)會(「董事會」)欣 然 宣 佈,本 公 司 之 附 屬 公 司 卓 悅 供 應 鏈 管 理 有限公司與紫元元控股集團有限公司(股份代號:8223 )(「紫元元」)於二零二五年 十二月十一日,就有關本集團可能與紫元元達成的戰略合作計劃(「可能合作計劃」) 訂立不具法律約束力的諒解備忘錄(「諒解備忘錄」),代表協議雙方的初步共識,而 可能合作須待協議雙方訂立正式合作協議方告落實。 ...
调查显示:上海老年人消费能力强,月均消费3300元!但对这些方面不太满意→
Sou Hu Cai Jing· 2025-12-09 08:03
Core Insights - The "silver economy" is a significant driver of consumption market upgrades in Shanghai, where the elderly population aged 60 and above accounts for 37.6% of the city's residents [1][53] - A recent survey highlights the disparity between the high evaluation of the consumption environment (77.43) and the lower satisfaction with consumption supply (68.41) among the elderly [3][8] Consumption Experience - Elderly respondents rated their consumption experience positively, with a score of 77.43, while satisfaction with supply was lower at 68.41 [3] - The highest satisfaction was found in cultural and entertainment products/services (70.72), while satisfaction with age-friendly renovation services was lower (61.08) [3][8] Regional Differences - Baoshan district received high ratings for consumption experience (89.25), supply (79.91), and environment (87.65), while Chongming district scored lower in all categories [8][9] - Pudong New Area had a low evaluation of the consumption environment (69.77), particularly regarding promotional policies and activities [8] Consumption Trends - The elderly in Shanghai have strong consumption capabilities and preferences for practicality and quality, with 46.8% having a monthly disposable income above 5000 yuan [11][14] - Monthly consumption expenditure of over 3000 yuan was reported by 48.0% of respondents, indicating a higher spending capacity compared to national averages [14] Key Consumption Categories - Major consumption areas include necessities like food (83.6%), housing (75.7%), and transportation (54.6%), with health-related spending also significant (67.8% for medical health) [14][16] - An increasing trend in spending was noted in food (69.0% increase), medical health (49.0%), and wellness products (40.7%) [14] Satisfaction with Services - 51.1% of elderly respondents expressed satisfaction with their recent consumption experiences, while 17.8% felt it was average or unsatisfactory, mainly due to price and quality issues [16] - In the medical health sector, 70.1% of respondents were satisfied with services, but concerns about community hospital capabilities were prevalent [19] Focus Areas for Improvement - The survey identified medical health (85.6% interest) and community care services as key areas for improvement, with a need for enhanced community hospital capabilities and service offerings [19][27] - In the entertainment sector, social interaction activities were highly valued (77.6%), but dissatisfaction stemmed from inadequate age-appropriate activities [23] Financial Products and Services - Interest in deposit-based financial products was high (81.9%), but only 55.4% expressed satisfaction, citing complex terms and high-risk levels as concerns [31] - Satisfaction with smart elderly care products was moderate, with 49.8% expressing contentment, but issues with pricing and complexity were noted [35] Recommendations for Policy and Market Adaptation - The report suggests enhancing community healthcare services, improving age-friendly renovations, and developing affordable smart health monitoring products to meet the needs of the elderly [53][54] - It also recommends expanding community meal services and integrating diverse care options to improve overall service quality [54][55]
南下资金“投票”平安好医生(1833.HK):连续7日增持背后的政策、资本与内功“三重奏”
Ge Long Hui· 2025-12-08 04:42
临近年末,跨年行情预期升温。在市场波动之中,聪明钱的流向往往揭示了确定性更高的方向。根据WIND数据显 示,平安好医生已连续7个交易日获得南下资金净流入,港股通持股占比已攀升至23.07%。 聪明资金的坚定布局,其背后是政策、资本与内功改善的合力驱动。这"三重奏"正推动平安好医生的投资逻辑步入一 个难得的共振时刻。 数据来源: WIND ,格隆汇整理 数据截至 2025 年 12 月 5 日收盘 三力共振,重估正当时 一、政策推力,为险资入市打开想象空间 近日,国家金融监督管理总局发布通知,优化保险公司偿付能力监管标准,调低了保险公司投资沪深300指数成分股 的风险因子。此项调整意味着保险资金进行权益投资的资本占用成本下降,实质上释放了更多的入市空间,旨在鼓励 长期资金加大对资本市场的支持力度。 对于平安好医生而言,这一政策是重要的间接但有力的积极信号。其控股股东中国平安作为国内最大的综合金融集团 之一,将直接受益于此项政策,其投资灵活性、资本实力及整体估值预期均有望得到提升。一个更强大的母公司,无 疑将为平安好医生的长期战略推进和生态业务协同,提供更坚实的后盾与更有利的资本环境。 二、资本外力:顶级机构一致 ...
进博会观察:链接全球健康产业,京东激活健康消费新势能
Xin Hua Wang· 2025-11-11 13:57
Core Insights - The 8th China International Import Expo (CIIE) is being held from November 5 to 10 in Shanghai, featuring participation from 155 countries, regions, and international organizations, with 4,108 overseas enterprises showcasing their products, highlighting the vitality of China's large-scale market and presenting new opportunities for the global economy [2][3] Company Summary - JD Health is leveraging the CIIE platform to deepen global cooperation, establish industry standards, and innovate service ecosystems, aiming to provide high-quality health resources to Chinese consumers while promoting the health industry towards inclusivity, professionalism, and scientific advancement [2][3] - JD Health serves as a crucial link between global health resources and the Chinese health consumption market, focusing on the domestic demand for high-quality health living, efficiently delivering innovative pharmaceutical products, scientific nutrition solutions, and medical devices to households [3] - The company is facilitating a low-barrier, high-efficiency market entry for global health brands, helping overseas enterprises quickly connect with Chinese market demands, and driving the deep integration of global health elements with domestic industrial chains [3] - JD Health's initiatives align with the "14th Five-Year Plan" which emphasizes a health-first development strategy, positioning the company to contribute to the high-quality development of the health industry and the well-being of the public through ongoing collaboration with global brands and the enhancement of its service ecosystem [3]